Literature DB >> 29250243

Efficacy of Catheter Ablation and Concomitant Antiarrhythmic Drugs on the Reduction of the Arrhythmia Burden in Patients with Long-Standing Persistent Atrial Fibrillation.

Atsuhiko Yagishita1, Yasuteru Yamauchi1, Hironori Sato1, Shu Yamashita1, Tatsuhiko Hirao1, Takamichi Miyamoto1, Kenzo Hirao2.   

Abstract

BACKGROUND: Little is known about the long-term outcome and recurrent form recurrence after catheter ablation of atrial fibrillation (AF) in patients with long-standing persistent AF.
METHODS: Two hundred thirty-six patients with persistent AF (193 men; age, 61.5±10.7 years) were enrolled, and were classified according to the duration of AF: AF duration of <1 year (group A, n=99), between 1 to 5 years (group B, n=101), and ≥5 years (group C, n=36). The long-term recurrence rate and recurrent form were compared among the groups.
RESULTS: During a median follow-up of 3.7 years, the recurrence rate was significantly worse in group C after the index and multiple procedures (Log-Rank, both for a P<0.001 in comparison to group A). In the multivariate analysis, the duration was an independent predictor of an arrhythmia recurrence (HR, 1.206; 95%CI, 1.053 to 1.381; P=0.007). Recurrent AF became permanent in 8 patients (3.4%), which was not associated with a difference in the groups (Log-rank, P=0.055), while antiarrhythmic drugs (AADs) were continued in 70% of the recurrent patients.
CONCLUSION: Despite a high AF recurrence rate in the patients with an AF duration of ≥5 years, the majority of the patients with recurrence who continued on AADs had a paroxysmal form of AF. Catheter ablation and concomitant AADs may be effective in reducing the AF burden in such patients with an advanced AF disease stage.

Entities:  

Keywords:  Antiarrhythmic drugs; Catheter ablation; Persistent atrial fibrillation

Year:  2017        PMID: 29250243      PMCID: PMC5725751          DOI: 10.4022/jafib.1649

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  25 in total

1.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Superior vena cava as initiator of atrial fibrillation: factors related to its arrhythmogenicity.

Authors:  Koji Higuchi; Yasuteru Yamauchi; Kenzo Hirao; Takeshi Sasaki; Hitoshi Hachiya; Yukio Sekiguchi; Junichi Nitta; Mitsuaki Isobe
Journal:  Heart Rhythm       Date:  2010-05-12       Impact factor: 6.343

3.  Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

4.  Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.

Authors:  Kensuke Takabayashi; Yasuhiro Hamatani; Yugo Yamashita; Daisuke Takagi; Takashi Unoki; Mitsuru Ishii; Moritake Iguchi; Nobutoyo Masunaga; Hisashi Ogawa; Masahiro Esato; Yeong-Hwa Chun; Hikari Tsuji; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Gregory Y H Lip; Masaharu Akao
Journal:  Stroke       Date:  2015-10-29       Impact factor: 7.914

Review 5.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

6.  Technique and results of linear ablation at the mitral isthmus.

Authors:  Pierre Jaïs; Mélèze Hocini; Li-Fern Hsu; Prashanthan Sanders; Christophe Scavee; Rukshen Weerasooriya; Laurent Macle; Florence Raybaud; Stéphane Garrigue; Dipen C Shah; Philippe Le Metayer; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2004-11-01       Impact factor: 29.690

7.  Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Authors:  Jelena Kornej; Gerhard Hindricks; Jedrzej Kosiuk; Arash Arya; Philipp Sommer; Daniela Husser; Sascha Rolf; Sergio Richter; Christopher Piorkowski; Thomas Gaspar; Gregory Y H Lip; Andreas Bollmann
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-09-18

8.  Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.

Authors:  Akira Fujiki; Takayuki Tsuneda; Masao Sakabe; Keiko Nakagawa; Koichi Mizumaki; Tadakazu Hirai; Hiroshi Inoue
Journal:  Circ J       Date:  2004-09       Impact factor: 2.993

9.  Sequential biatrial linear defragmentation approach for persistent atrial fibrillation.

Authors:  Shinsuke Miyazaki; Hiroshi Taniguchi; Yuki Komatsu; Takashi Uchiyama; Shigeki Kusa; Hiroaki Nakamura; Hitoshi Hachiya; Mitsuaki Isobe; Kenzo Hirao; Yoshito Iesaka
Journal:  Heart Rhythm       Date:  2012-12-02       Impact factor: 6.343

10.  Nationwide survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J-CARAF)-A report on periprocedural oral anticoagulants.

Authors:  Yuji Murakawa; Akihiko Nogami; Morio Shoda; Koichi Inoue; Shigeto Naito; Koichiro Kumagai; Yasushi Miyauchi; Teiichi Yamane; Norishige Morita; Hideo Mitamura; Ken Okumura
Journal:  J Arrhythm       Date:  2014-07-05
View more
  1 in total

Review 1.  Sex Differences in Atrial Fibrillation-Update on Risk Assessment, Treatment, and Long-Term Risk.

Authors:  Charlotte J Bai; Nidhi Madan; Shaza Alshahrani; Neelum T Aggarwal; Annabelle Santos Volgman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.